Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lacks adequate coverage.
Our team of highly experienced analysts provides a wide range of tailored services in the field of equity, investment and financial research and investor relations to our diversified client base around the world.
Our free mobile app gives you real-time notifications on publication of short company stories for compelling investment ideas so that you never miss an opportunity!
As a step to effectively handle your research team’s workload as a business partner, our free mobile (and tablet friendly) application, also offer you a complete accessibility in tracking your project progress and billing and payment status at the tip of your finger any time.
Download the app for free now to explore our talent pool and feel the difference in outsourcing your work to us.
We pride ourselves in constantly delivering high-quality and scalable equity, investment and credit research solutions to our diversified client base across 9 countries. A snapshot of our key experience in past 3 years includes:
Earlier this year, we had covered some path-breaking companies engaged in clinical trials, to test the efficacy and safe...18 July, 2019No comment
Medigus Ltd, (NASDAQ:MDGS) a pioneer in developing cutting-edge minimally invasive surgical tools and imaging solutions ...17 July, 2019No comment
Prostate Cancer is the second leading cause of death in men in the U.S, with over 1 in 41 men likely to succumb to the d...16 July, 2019No comment
Ovid Therapeutics (NASDAQ: OVID), a biopharmaceutical company developing novel therapeutics for rare neurological disord...02 July, 2019No comment
GrowLife, Inc (OTCPK: PHOT), a pioneer in the cultivation equipment provider space, announced an agreement with Emerald ...29 June, 2019No comment
ParcelPal Technologies (CNSX: PKG) (OTCPK: PTNYF), a Canadian on-demand local delivery service provider, announced the c...26 June, 2019No comment
Liberty Defense Holdings (OTCPK: LDDFF), a pioneer in security solutions dealing with detection of concealed weapons in ...24 June, 2019No comment
Sirona Biochem (OTCPK: SRBCF), a biopharmaceutical company focused on discovering novel cosmetic and pharmaceutical comp...21 June, 2019No comment
Standing Tall ReWalk Robotics (NASDAQ: RWLK) recently received an approval for its ReStore exoskeleton system, indicate...19 June, 2019No comment
Human Immunodeficiency Virus (HIV) compromises the body’s immunity by attacking CD4 cells (a type of T cell), exposing...18 June, 2019No comment
Obalon Therapeutics (NASDAQ: OBLN), the manufacturer of the first and only FDA-approved swallowable, gas-filled intragas...14 June, 2019No comment
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinica...12 June, 2019No comment
Imagination Park Technologies Inc. (CSE: IP) (OTCQB: IPNFF), an augmented reality (AR) platform, announced that it has ...11 June, 2019No comment
Avise Analytics is a professionally managed organization and understood job scopes & requirements very well. The report and analysis generated meet my expectations and will not hesitate to recommend others.
Delivered a high-quality set of documents that exceeded my expectations. Keep up the good work!!
Great team. We ramped up our coverage universe quickly due to their help. I highly recommend them!
High quality equity research provider that we now use for regular work
Excellent communication skills and a high commitment to client satisfaction.
Instrumental in helping us complete the research in such a tight timeline!
I have found Avise Analytics to be a great, cost-effective solution to providing both simple and complex finance-related articles for various blogs and newsletters. They are detailed oriented, consciences, respond well to direction, prompt and really know the finance industry.